← Evidence map

ArticleInfectious diseases and therapy2026

Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam-Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales.

Susan R Raber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41269522